Holen Sie sich die Stockscreener-App
18.76
1.52%
-0.29
Handel nachbörslich:
19.00
0.24
+1.28%
Schlusskurs vom Vortag:
$19.05
Offen:
$19
24-Stunden-Volumen:
4.64M
Relative Volume:
0.67
Marktkapitalisierung:
$9.32B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
46.90
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
+5.10%
1M Leistung:
+12.54%
6M Leistung:
+68.40%
1J Leistung:
+26.93%
1-Tages-Spanne:
$18.56
$19.07
1-Wochen-Bereich:
$17.11
$19.07
52-Wochen-Spanne:
$8.02
$19.07
Elanco Animal Health Inc Stock (ELAN) Company Profile
Firmenname
Elanco Animal Health Inc
Sektor
Telefon
877-352-6261
Adresse
2500 INNOVATION WAY, GREENFIELD
Vergleichen Sie ELAN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
18.76 | 9.46B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
149.79 | 67.25B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.27 | 48.23B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.75 | 43.59B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.68 | 22.14B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
403.80 | 17.85B | 2.99B | 1.21B | 1.13B | 25.06 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Eingeleitet | UBS | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-09-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-19 | Eingeleitet | Jefferies | Buy |
| 2023-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-04-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Sell |
| 2022-07-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-28 | Herabstufung | Stifel | Buy → Hold |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-06-15 | Hochstufung | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Eingeleitet | Stifel | Buy |
| 2021-03-22 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Herabstufung | Argus | Buy → Hold |
| 2020-11-09 | Herabstufung | Barclays | Overweight → Underweight |
| 2020-08-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Fortgesetzt | Credit Suisse | Neutral |
| 2020-08-04 | Fortgesetzt | Goldman | Buy |
| 2020-07-27 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-19 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Eingeleitet | Barclays | Overweight |
| 2019-08-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-03-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Eingeleitet | William Blair | Mkt Perform |
| 2019-01-23 | Eingeleitet | UBS | Sell |
| 2019-01-15 | Eingeleitet | Argus | Buy |
| 2018-10-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten
Elanco CEO Says Blockbuster Drugs Driving Business - MarketScreener
Why Elanco (ELAN) Stock Is Trading Up Today - uk.finance.yahoo.com
Elanco Animal Health stock hits 52-week high at $18.88 By Investing.com - Investing.com Canada
Elanco Animal Health’s Valuation in Focus After Breakthroughs for Credelio Quattro and Zenrelia Products - Yahoo Finance
Elanco’s Credelio Quattro hits $100 million sales milestone By Investing.com - Investing.com Canada
Elanco’s Credelio Quattro hits $100 million sales milestone - Investing.com
Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status - PR Newswire
Companion Animal Health Market is expected to reach US$ 56.60 - openPR.com
State’s exit from GM site ownership signals new economic development approach - Inside INdiana Business
Using data models to predict Elanco Animal Health Incorporated stock movementSwing Trade & Daily Stock Trend Reports - Newser
How do insiders feel about Elanco Animal Health IncorporatedGlobal Markets & AI Driven Stock Reports - خودرو بانک
What’s the outlook for Elanco Animal Health Incorporated’s sector2025 Fundamental Recap & Weekly Breakout Watchlists - خودرو بانک
Can you recover from losses in Elanco Animal Health Incorporated2025 Market Trends & Fast Entry High Yield Stock Tips - Newser
Can Elanco Animal Health Incorporated recover in the next quarterQuarterly Performance Summary & Target Return Focused Stock Picks - Newser
How to use a screener to detect Elanco Animal Health Incorporated breakoutsJuly 2025 Fed Impact & Weekly High Return Opportunities - Newser
Analyzing recovery setups for Elanco Animal Health Incorporated investorsMarket Growth Review & Capital Protection Trade Alerts - Newser
Future of Animal Parasiticides Market: Sustainable - openPR.com
Tools to monitor Elanco Animal Health Incorporated recovery probabilityPortfolio Return Report & Stock Portfolio Risk Management - Newser
Elanco (ELAN) Q2 Revenue Jumps 5% - AOL.com
Can momentum traders help lift Elanco Animal Health IncorporatedAnalyst Upgrade & Daily Profit Focused Stock Screening - Newser
Should you wait for a breakout in Elanco Animal Health Incorporated2025 Trading Recap & Precise Trade Entry Recommendations - Newser
Poultry Antibiotic Market to Witness Massive Growth by 2032 | - openPR.com
What indicators show strength in Elanco Animal Health IncorporatedJuly 2025 Breakouts & Weekly High Potential Stock Alerts - Newser
Will Elanco Animal Health Incorporated outperform the marketTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
Will Elanco Animal Health Incorporated benefit from current market trendsPortfolio Gains Summary & Safe Capital Growth Tips - خودرو بانک
Can volume confirm reversal in Elanco Animal Health Incorporated2025 Earnings Impact & Low Volatility Stock Recommendations - Newser
Why Elanco (ELAN) Stock Is Trading Lower Today - Yahoo Finance
Is Elanco Animal Health Incorporated a good ESG investmentMarket Sentiment Review & Proven Capital Preservation Tips - خودرو بانک
Buyout Rumor: What is Elanco Animal Health Incorporated s P E ratio telling usEarnings Miss & Weekly High Momentum Picks - خودرو بانک
Smart tools for monitoring Elanco Animal Health Incorporated’s price action2025 Valuation Update & High Yield Stock Recommendations - Newser
Using data tools to time your Elanco Animal Health Incorporated exitPortfolio Value Summary & Accurate Buy Signal Alerts - Newser
Veterinary Oncology Market Shares, Competition and Trends Analysis 2025-2030: Discover the Impact of Advanced Therapies and Digital Tools - GlobeNewswire Inc.
Rally Mode: Is now the right time to enter Elanco Animal Health Incorporated2025 Fundamental Recap & AI Forecasted Entry and Exit Points - خودرو بانک
Should I buy Elanco Animal Health Incorporated stock nowJuly 2025 Institutional & Technical Buy Zone Confirmations - خودرو بانک
Published on: 2025-09-03 07:49:06 - خودرو بانک
Is now the right time to enter Elanco Animal Health Incorporated2025 Valuation Update & Weekly Sector Rotation Insights - خودرو بانک
Using data filters to optimize entry into Elanco Animal Health IncorporatedWeekly Trade Review & Daily Profit Maximizing Tips - Newser
What technical models suggest about Elanco Animal Health Incorporated’s comebackJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Unpacking Q2 Earnings: Elanco (NYSE:ELAN) In The Context Of Other Pharmaceuticals Stocks - FinancialContent
Is Elanco Animal Health Incorporated stock ready for a breakoutWeekly Stock Analysis & Daily Price Action Insights - Newser
Elanco Animal Health's Index Inclusion as a Catalyst for Institutional Demand and Market Re-rating - AInvest
Elanco Animal Health's Inclusion in the S&P MidCap 400: A Catalyst for Institutional Demand and Share Price Momentum - AInvest
Elanco Animal Health’s Inclusion in the S&P MidCap 400: A Catalyst for Institutional Interest and Shareholder Value - AInvest
Elanco Animal Health Incorporated(NYSE: ELAN) added to S&P 1000 - MarketScreener
Elanco Animal Health Incorporated Added to S&P 400: A Focus on Animal Health Products and Services - AInvest
Elanco Animal Health Incorporated(NYSE: ELAN) added to S&P 400 Health Care - MarketScreener
Elanco Animal Health Incorporated(NYSE: ELAN) added to S&P Composite 1500 - MarketScreener
Elanco Animal Health Incorporated(NYSE: ELAN) added to S&P 400 - MarketScreener
Should I set a stop loss on Elanco Animal Health Incorporated2025 Earnings Impact & Verified Technical Signals - khodrobank.com
Fed Watch: Is Elanco Animal Health Incorporated forming a bullish divergenceMarket Performance Report & Short-Term Trading Opportunity Alerts - خودرو بانک
Published on: 2025-09-01 19:22:50 - خودرو بانک
Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Elanco Animal Health Inc-Aktie (ELAN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kurzius Lawrence Erik | Director |
Mar 07 '25 |
Buy |
10.90 |
10,000 |
109,000 |
101,459 |
| Kurzius Lawrence Erik | Director |
Mar 11 '25 |
Buy |
10.20 |
10,000 |
102,000 |
111,459 |
| HOOVER R DAVID | Director |
Mar 05 '25 |
Buy |
10.90 |
25,000 |
272,558 |
210,000 |
2.24%
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):